Back
Supernus Pharmaceuticals, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
34
SUPN
Supernus Pharmaceuticals, Inc.
Last Price:
$45.07
Seasonality Move:
-0.27%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Supernus Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.22 | Sell |
| 20-day SMA: | 45.32 | Sell |
| 50-day SMA: | 48.42 | Sell |
| 200-day SMA: | 38.49 | Buy |
| 8-day EMA: | 45.09 | Buy |
| 20-day EMA: | 46.1 | Sell |
| 50-day EMA: | 46.72 | Sell |
| 200-day EMA: | 41.09 | Buy |
Supernus Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.12 | Sell |
| Relative Strength Index (14 RSI): | 42.74 | Sell |
| Chaikin Money Flow: | 493658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.12 - 51.1) | Sell |
| Bollinger Bands (100): | (39.21 - 50.45) | Buy |
Supernus Pharmaceuticals, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals, Inc. Stock
Is Supernus Pharmaceuticals, Inc. Stock a Buy?
-
Supernus Pharmaceuticals, Inc. share price is 45.10 while SUPN 8-day simple moving average is 45.22, which is a Sell signal.
-
The stock price of SUPN is 45.10 while Supernus Pharmaceuticals, Inc. 20-day SMA is 45.32, which makes it a Sell.
-
Supernus Pharmaceuticals, Inc. 50-day simple moving average is 48.42 while SUPN share price is 45.10, making it a Sell technically.
-
SUPN stock price is 45.10 and Supernus Pharmaceuticals, Inc. 200-day simple moving average is 38.49, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
34
Supernus Pharmaceuticals, Inc. (SUPN)
is a Sell
Is Supernus Pharmaceuticals, Inc. a Buy or a Sell?
-
Supernus Pharmaceuticals, Inc. stock is rated a SellThe current Supernus Pharmaceuticals, Inc. [SUPN] share price is $45.10. The Score for SUPN is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals, Inc. Stock Info
Market Cap:
2.6B
Price in USD:
45.10
Share Volume:
493.7K
Supernus Pharmaceuticals, Inc. 52-Week Range
52-Week High:
57.65
52-Week Low:
29.16
Sell
34
Supernus Pharmaceuticals, Inc. (SUPN)
is a Sell
Supernus Pharmaceuticals, Inc. Share Price Forecast
-
What is the Supernus Pharmaceuticals, Inc. stock price today?The Supernus Pharmaceuticals, Inc. stock price is 45.10 USD today.
-
Will SUPN stock go up or go down?Supernus Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Supernus Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals, Inc. is overvalued.
Is Supernus Pharmaceuticals, Inc. Stock a Buy?
-
Supernus Pharmaceuticals, Inc. share price is 45.10 while SUPN 8-day exponential moving average is 45.09, which is a Buy signal.
-
The stock price of SUPN is 45.10 while Supernus Pharmaceuticals, Inc. 20-day EMA is 46.10, which makes it a Sell.
-
Supernus Pharmaceuticals, Inc. 50-day exponential moving average is 46.72 while SUPN share price is 45.10, making it a Sell technically.
-
SUPN stock price is 45.10 and Supernus Pharmaceuticals, Inc. 200-day simple moving average is 41.09, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals, Inc.
Is Supernus Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.43 per share.
Technical Analysis of Supernus Pharmaceuticals, Inc.
Should I short Supernus Pharmaceuticals, Inc. stock?
-
SUPN Moving Average Covergence Divergence (MACD) indicator is -1.12, suggesting Supernus Pharmaceuticals, Inc. is a Sell
-
Supernus Pharmaceuticals, Inc. Relative Strength Index (RSI) is 42.74, which suggest Supernus Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Supernus Pharmaceuticals, Inc. is (43.12 - 51.1), which suggest Supernus Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Supernus Pharmaceuticals, Inc. is (39.21 - 50.45), which suggest Supernus Pharmaceuticals, Inc. is a Buy
* Supernus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.